Cargando…
Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles
Furosemide (FSM) is commonly used in the treatment of edema associated with congestive cardiac failure, cirrhosis of the liver, renal disease, including the nephrotic syndrome and hypertension. However, in ascites, it is clinically limited due to its frequent dosing and short biological half-life an...
Autores principales: | Kashyap, Sapna, Singh, Amit, Mishra, Abha, Singh, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791168/ https://www.ncbi.nlm.nih.gov/pubmed/31620185 http://dx.doi.org/10.4103/1735-5362.253356 |
Ejemplares similares
-
Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery
por: Lu, Boting, et al.
Publicado: (2019) -
Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020) -
Cross-Linked Dependency of Boronic Acid-Conjugated Chitosan Nanoparticles by Diols for Sustained Insulin Release
por: Siddiqui, Nabil A., et al.
Publicado: (2016) -
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022) -
Evaluation of Cell
Proliferation and Wound Healing
Effects of Vitamin A Palmitate-Loaded PLGA/Chitosan-Coated PLGA Nanoparticles:
Preparation, Characterization, Release, and Release Kinetics
por: Baghirova, Lala, et al.
Publicado: (2023)